A team published DeepSomatic in Nature Biotechnology as a somatic small‑variant caller that works across short‑ and long‑read sequencing technologies and released seven public somatic variant benchmarks (CASTLE‑panel). The tool and datasets aim to standardize somatic variant calling in cancer genomics, addressing a lack of long‑read callers and public benchmarks. Authors noted the combination of model and benchmarks will help labs integrate long‑read data into clinical somatic workflows.